G protein-coupled receptor 30 mediates cell proliferation of goat mammary epithelial cells via MEK/ERK&PI3K/AKT signaling pathway

References

• Marius LN, Shipandeni MNT, Togarepi C. Review on the status of goat production, marketing, challenges and opportunities in Namibia. Trop Anim Health Prod. 2020;53(1):30.
   PubMedGoogle Scholar
• Tripathi MK. Comforts in quality and production of goat milk. J Adv Dairy Res. 2015;03(1):1–2.
   Google Scholar
• Inman JL, Robertson C, Mott JD, et al. Mammary gland development: cell fate specification, stem cells and the microenvironment. Development. 2015;142(6):1028–1042.
   PubMed Web of Science ®Google Scholar
• Rezaei R, Wu Z, Hou Y, et al. Amino acids and mammary gland development: nutritional implications for milk production and neonatal growth. J Anim Sci Biotechnol. 2016;7(1):20.
   PubMedGoogle Scholar
• Hassiotou F, Geddes D. Anatomy of the human mammary gland: current status of knowledge. Clin Anat. 2013;26(1):29–48.
   PubMed Web of Science ®Google Scholar
• Macias H, Hinck L. Mammary gland development. Wiley Interdiscip Rev Dev Biol. 2012;1(4):533–557.
   PubMed Web of Science ®Google Scholar
• Alex A, Bhandary E, McGuire KP. Anatomy and physiology of the breast during pregnancy and lactation. Adv Exp Med Biol. 2020;1252:3–7.
   PubMedGoogle Scholar
• Hilton HN, Clarke CL, Graham JD. Estrogen and progesterone signalling in the normal breast and its implications for cancer development. Mol Cell Endocrinol. 2018;466:2–14.
   PubMed Web of Science ®Google Scholar
• Barton M, Filardo EJ, Lolait SJ, et al. Twenty years of the G protein-coupled estrogen receptor GPER: historical and personal perspectives. J Steroid Biochem Mol Biol. 2018;176:4–15.
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol. 2011;7(12):715–726.
   PubMed Web of Science ®Google Scholar
• Urrego D, Tomczak AP, Zahed F, et al. Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci. 2014;369(1638):20130094.
   PubMed Web of Science ®Google Scholar
• Dai WT, White RR, Liu JX, et al. Seryl-tRNA synthetase-mediated essential amino acids regulate β-casein synthesis via cell proliferation and mammalian target of rapamycin (mTOR) signaling pathway in bovine mammary epithelial cells. J Dairy Sci. 2018;101(11):10456–10468.
   PubMed Web of Science ®Google Scholar
• Jiao BL, Zhang XL, Wang SH, et al. MicroRNA-221 regulates proliferation of bovine mammary gland epithelial cells by targeting the STAT5a and IRS1 genes. J Dairy Sci. 2019;102(1):426–435.
   PubMed Web of Science ®Google Scholar
• Zhu P, Liao LY, Zhao TT, et al. GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells. Mol Cell Endocrinol. 2017;442:68–80.
   PubMed Web of Science ®Google Scholar
• Chan QK, Lam HM, Ng CF, et al. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of ERK1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ. 2010;17(9):1511–1523.
   PubMed Web of Science ®Google Scholar
• Ribeiro MPC, Santos AE, Custódio JBA. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells. Chem Biol Interact. 2017;277:176–184.
   PubMedGoogle Scholar
• Hernández-Silva CD, Villegas-Pineda JC, Pereira-Suárez AL. Expression and role of the g protein-coupled estrogen receptor (GPR30/GPER) in the development and immune response in female reproductive cancers. Front Endocrinol. 2020;11:544.
   PubMed Web of Science ®Google Scholar
• Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol. 2002;80(2):231–238.
   PubMedGoogle Scholar
• Filardo EJ, Quinn JA, Bland KI, et al. Estrogen-induced activation of ERK-1 and ERK-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000;14(10):1649–1660.
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Quinn JA, Frackelton AR Jr., et al. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002;16(1):70–84.
   PubMed Web of Science ®Google Scholar
• Ge LC, Chen ZJ, Liu HY, et al. Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol a promoting growth of sertoli TM4 cells. Toxicol Lett. 2014;226(1):81–89.
   PubMedGoogle Scholar
• He YY, Cai B, Yang YX, et al. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci. 2009;100(6):1051–1061.
   PubMed Web of Science ®Google Scholar
• Scaling AL, Prossnitz ER, Hathaway HJ. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Horm Cancer. 2014;5(3):146–160.
   PubMedGoogle Scholar
• Dennis MK, Burai R, Ramesh C, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009;5(6):421–427.
   PubMed Web of Science ®Google Scholar
• Dennis MK, Field AS, Burai R, et al. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol. 2011;127(3–5):358–366.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhang Z, Liao H, et al. Nuclear estrogen receptor-mediated notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Oncol Rep. 2012;27(2):504–510.
   PubMed Web of Science ®Google Scholar
• Li C, Wang M, Zhang T, et al. Insulin-induced gene 1 and 2 isoforms synergistically regulate triacylglycerol accumulation, lipid droplet formation, and lipogenic gene expression in goat mammary epithelial cells. J Dairy Sci. 2019;102(2):1736–1746.
   PubMedGoogle Scholar
• Tong HL, Li QZ, Gao XJ, et al. Establishment and characterization of a lactating dairy goat mammary gland epithelial cell line. Vitro Cell Dev Biol Anim. 2012;48(3):149–155.
   PubMedGoogle Scholar
• Yang D, Jiang T, Lin P, et al. Knock-down of apoptosis inducing factor gene protects endoplasmic reticulum stress-mediated goat granulosa cell apoptosis. Theriogenology. 2017;88:89–97.
   PubMed Web of Science ®Google Scholar
• Kaushik R, Singh KP, Kumari A, et al. Isolation, characterization, and EGFP expression in the buffalo (Bubalus bubalis) mammary gland epithelial cell line. Vitro Cell Dev Biol Anim. 2013;49(1):1–7.
   PubMedGoogle Scholar
• Zheng YM, He XY, Zhang Y. Characteristics and EGFP expression of goat mammary gland epithelial cells. Reprod Domest Anim. 2010;45(6):e323–331.
   PubMedGoogle Scholar
• Hu H, Wang J, Bu D, et al. In vitro culture and characterization of a mammary epithelial cell line from Chinese holstein dairy cow. PLoS One. 2009;4(11):e7636.
   PubMedGoogle Scholar
• Thu KL, Soria-Bretones I, Mak TW, et al. Targeting the cell cycle in breast cancer: towards the next phase. Cell Cycle. 2018;17(15):1871–1885.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang Y, Zhang Z, et al. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway. Cancer Lett. 2013;339(2):279–287.
   PubMedGoogle Scholar
• Chuang SC, Chen CH, Chou YS, et al. G protein-coupled estrogen receptor mediates cell proliferation through the cAMP/PKA/CREB pathway in murine bone marrow mesenchymal stem cells. Int J Mol Sci. 2020;21(18):6490.
   PubMed Web of Science ®Google Scholar
• Holm A, Baldetorp B, Olde B, et al. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res. 2011;48(4):327–335.
   PubMedGoogle Scholar
• Zhong J, Ge HF, Zhang C, et al. G protein-coupled estrogen receptor 1 negatively regulates the proliferation of mouse-derived neural stem/progenitor cells via extracellular signal-regulated kinase pathway. Brain Res. 2019;1714:158–165.
   PubMedGoogle Scholar
• Liu H, Yan Y, Wen H, et al. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells. Cell Biol Int. 2014;38(5):631–638.
   PubMed Web of Science ®Google Scholar
• Bai LY, Weng JR, Hu JL, et al. G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells. Chem Biol Interact. 2013;206(2):375–384.
   PubMedGoogle Scholar
• Chaturantabut S, Shwartz A, Evason KJ, et al. Estrogen activation of g-protein-coupled estrogen receptor 1 regulates phosphoinositide 3-kinase and mTOR signaling to promote liver growth in zebrafish and proliferation of human hepatocytes. Gastroenterology. 2019;156(6):1788–1804.e1713.
   PubMedGoogle Scholar
• Gui Y, Shi Z, Wang Z, et al. The GPER agonist G-1 induces mitotic arrest and apoptosis in human vascular smooth muscle cells independent of GPER. J Cell Physiol. 2015;230(4):885–895.
   PubMedGoogle Scholar
• Wang C, Lv X, He C, et al. The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization. Cell Death Dis. 2013;4(10):e869.
   PubMedGoogle Scholar
• Alenzi FQ. Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci. 2004;61(2):99–102.
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342–348.
   PubMed Web of Science ®Google Scholar
• Barbosa R, Acevedo LA, Marmorstein R. The MEK/ERK network as a therapeutic target in human cancer. Mol Cancer Res. 2021;19(3):361–374.
   PubMed Web of Science ®Google Scholar
• Yu JS, Cui W. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development. 2016;143(17):3050–3060.
   PubMed Web of Science ®Google Scholar
• Akimoto T, Takasawa A, Takasawa K, et al. Estrogen/GPR30 signaling contributes to the malignant potentials of ER-negative cervical adenocarcinoma via regulation of claudin-1 expression. Neoplasia. 2018;20(10):1083–1093.
   PubMedGoogle Scholar
• Chen Y, Li Z, He Y, et al. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014;275(2):176–181.
   PubMedGoogle Scholar
• Grassi D, Lagunas N, Pinos H, et al. NADPH-diaphorase colocalizes with GPER and is modulated by the GPER agonist G1 in the supraoptic and paraventricular nuclei of ovariectomized female rats. Neuroendocrinology. 2017;104(1):94–104.
   PubMedGoogle Scholar
• Xu L, Chen J, Jia L, et al. SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway. J Cell Mol Med. 2020;24(24):14392–14404.
   PubMed Web of Science ®Google Scholar
• Ni S, Wei Q, Yang L. ADORA1 promotes hepatocellular carcinoma progression via PI3K/AKT pathway. Onco Targets Ther. 2020;13:12409–12419.
   PubMedGoogle Scholar